2019 American Transplant Congress
Using Multidimensional Quality of Life Measurement to Better Understand the Benefit of Living Donor Kidney Transplant
Northwestern University, Chicago, IL
*Purpose: Patient and graft survival after living donor kidney transplant (LDKT) are generally excellent, but there remains some variation in health-related quality of life (HRQOL)…2019 American Transplant Congress
Effectiveness Of The Vittal Viability Criteria During Ex Situ Normothermic Machine Perfusion To Discriminate Hepatobiliary Organ Injury And Investigation Of Biochemical Markers For Post-transplant Complications
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
*Purpose: The VITTAL (viability testing and transplantation of marginal livers) clinical trial demonstrated that ex situ end-ischaemic normothermic machine perfusion (NMP) allows functional assessment and…2019 American Transplant Congress
Kidney Grafts From Donors After Circulatory Death Provide Comparable Outcome To Donors After Brain Death Without Intracorporeal In Situ Cooling
Sapporo City General Hospital, Sapporo, Hokkaido, Japan
*Purpose: Donation after circulatory death (DCD) had been one and only source of deceased kidney donor in our country. The number of donation after brand…2019 American Transplant Congress
Oral Preconditioning of Donors after Brain Death with Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation
*Purpose: The systemic inflammatory cascade triggered in donors after brain death (DBD) enhances the ischemia-reperfusion injury (IRI) after organ transplantation. Data regarding donor preconditioning with…2019 American Transplant Congress
CYP3A5 Genotype Had No Influence on Renal Function after Renal Transplantation
*Purpose: Tacrolimus metabolism rate has been reported to be associated with renal function after renal transplantation (Thölking et al., 2014); this study aimed to determine…2019 American Transplant Congress
Evaluation of Envarsus XR in African American Kidney Transplant Recipients
1Pharmacy, Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, IL
*Purpose: This study is being conducted to evaluate the clinical impact of the utilization of tacrolimus LCP (TAC-LCP) compared to tacrolimus immediate release (TAC-IR) in…2019 American Transplant Congress
Outcomes in Kidney Transplant Recipients after Conversion from Tacrolimus to Belatacept-Based Regimens
Columbia University Irving Medical Center, New York, NY
*Purpose: Immunosuppressive strategies for belatacept are variable and associated outcomes have not been well described. We examined outcomes among kidney transplant (KT) recipients converted from…2019 American Transplant Congress
Long-Term Kidney Graft Evolution in Simultaneous Liver-Kidney Transplants with Immunological Risk
*Purpose: There is disagreement about the real impact of anti-HLA sensitization on patient and kidney graft survival in simultaneous liver-kidney transplant (SLKT).*Methods: We reviewed the…2019 American Transplant Congress
Outcomes of Inguinal and Incisional Hernias in Patients Undergoing Liver Transplant
Transplant Surgery, USC, Los Angeles, CA
*Purpose: To evaluate outcomes of patients with inguinal and incisional hernias at the time of liver transplant.*Methods: We performed a retrospective analysis of our prospectively…2019 American Transplant Congress
Liver Transplantation for Acute Liver Failure: A 16 Year Experience with 214 Patients in the Post-MELD Era
Department of Surgery, The Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Liver transplantation (LT) remains the gold standard treatment for acute liver failure (ALF). Our center has previously reported outcomes in the pre-Model for End…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 214
- Next Page »